Ranbaxy Loses Dismissal Bid In Roche Patent Spat

Law360, New York (March 19, 2008, 12:00 AM EDT) -- A federal judge dismissed Ranbaxy Laboratories Ltd.'s motion for summary judgment Monday in a patent infringement suit launched by Roche Palo Alto LLC over Roche's patent for Valcyte, an antiviral drug.

Judge Freda L. Wolfson of the U.S. District Court for the District of New Jersey discounted the generic drugmaker's argument that the Roche patent is invalid because the patent originally issued by the U.S. Patent and Trademark Office incorrectly omitted the names of two of the inventors.

Ranbaxy sought to invalidate Roche's patent for valganciclovir...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.